15 Einträge gefunden

1. Intensive chemotherapy with or without gemtuzumab ozogamicin in patients with NPM1-mutated acute myeloid leukaemia (AMLSG 09-09): a randomised, open-label, multicentre, phase 3 trial

   1. Döhner, Hartmut
   2. Weber, Daniela
   3. Krzykalla, Julia
   4. Fiedler, Walter
   5. Kühn, Michael W M
   6. Schroeder, Thomas
   7. Mayer, Karin

   2023 - Forschungsinformationssystem des UKE
2. Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT

   1. Nagler, Arnon
   2. Ngoya, Maud
   3. Galimard, Jacques-Emmanuel
   4. Labopin, Myriam
   5. Kröger, Nicolaus
   6. Socié, Gerard
   7. Gedde-Dahl, Tobias

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. Midostaurin plus intensive chemotherapy for younger and older Patients with AML and FLT3 internal tandem duplications

   1. Döhner, Hartmut
   2. Weber, Daniela
   3. Krzykalla, Julia
   4. Fiedler, Walter
   5. Wulf, Gerald Georg
   6. Salih, Helmut R
   7. Lübbert, Michael

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. High Molecular and Cytogenetic Risk in Myelofibrosis Does Not Benefit From Higher Intensity Conditioning Before Hematopoietic Cell Transplantation: An International Collaborative Analysis

   1. Gagelmann, Nico
   2. Salit, Rachel B
   3. Schroeder, Thomas
   4. Badbaran, Anita
   5. Rautenberg, Christina
   6. Panagiota, Victoria
   7. Wolschke, Christine

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
5. Reduced intensity hematopoietic stem cell transplantation for accelerated-phase myelofibrosis

   1. Gagelmann, Nico
   2. Wolschke, Christine
   3. Salit, Rachel B
   4. Schroeder, Thomas
   5. Ditschkowski, Markus
   6. Panagiota, Victoria
   7. Cassinat, Bruno

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
6. Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT

   1. Koenecke, Christian
   2. Eikema, Dirk-Jan
   3. Hazelaar, Sheree
   4. Schroeder, Thomas
   5. Potter, Victoria
   6. Kröger, Nicolaus
   7. Bornhäuser, Martin

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
7. Correction: Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT

   1. Nagler, Arnon
   2. Ngoya, Maud
   3. Galimard, Jacques-Emmanuel
   4. Labopin, Myriam
   5. Kröger, Nicolaus
   6. Socié, Gerard
   7. Gedde-Dahl, Tobias

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
8. Cluster of differentiation 33 single nucleotide polymorphism rs12459419 is a predictive factor in patients with nucleophosmin1 mutated acute myeloid leukemia receiving gemtuzumab ozogamicin

   1. Teich, Katrin
   2. Krzykalla, Julia
   3. Kapp-Schwoerer, Silke
   4. Gaidzik, Verena I
   5. Schlenk, Richard F
   6. Paschka, Peter
   7. Weber, Daniela

   2021 - Forschungsinformationssystem des UKE
9. Gemtuzumab Ozogamicin in NPM1-Mutated Acute Myeloid Leukemia: Early Results From the Prospective Randomized AMLSG 09-09 Phase III Study

   1. Schlenk, Richard F
   2. Paschka, Peter
   3. Krzykalla, Julia
   4. Weber, Daniela
   5. Kapp-Schwoerer, Silke
   6. Gaidzik, Verena I
   7. Leis, Claudia

   2020 - Forschungsinformationssystem des UKE
10. Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group

    1. Rücker, Frank G
    2. Agrawal, Mridul
    3. Corbacioglu, Andrea
    4. Weber, Daniela
    5. Kapp-Schwoerer, Silke
    6. Gaidzik, Verena I
    7. Jahn, Nikolaus

    2019 - Forschungsinformationssystem des UKE
11. Midostaurin added to chemotherapy and continued single agent maintenance therapy in acute myeloid leukemia with FLT3-ITD

    1. Schlenk, Richard F
    2. Weber, Daniela
    3. Fiedler, Walter
    4. Salih, Helmut R
    5. Wulf, Gerald
    6. Salwender, Hans
    7. Schroeder, Thomas

    2019 - Forschungsinformationssystem des UKE
12. Impact of ruxolitinib pretreatment on outcomes after allogeneic stem cell transplantation in patients with myelofibrosis

    1. Shahnaz Syed Abd Kadir, Sharifah
    2. Christopeit, Maximilian
    3. Wulf, Gerald
    4. Wagner, Eva
    5. Bornhauser, Martin
    6. Schroeder, Thomas
    7. Crysandt, Martina

    2018 - Forschungsinformationssystem des UKE
13. Postallogeneic monitoring with molecular markers detected by pretransplant next-generation or Sanger sequencing predicts clinical relapse in patients with myelodysplastic/myeloproliferative neoplasms

    1. Fu, Yuewen
    2. Schroeder, Thomas
    3. Zabelina, Tatiana
    4. Badbaran, Anita
    5. Bacher, Ulrike
    6. Kobbe, Guido
    7. Ayuketang, Francis Ayuk

    2014 - Forschungsinformationssystem des UKE
14. Treatment of Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse after Allogeneic Stem Cell Transplantation with Azacitidine and Donor Lymphocyte Infusions-A Retrospective Multicenter Analysis from the German Cooperative Transplant Study Group

    1. Schroeder, Thomas
    2. Rachlis, Elena
    3. Bug, Gesine
    4. Stelljes, Matthias
    5. Klein, Stefan
    6. Steckel, Nina Kristin
    7. Wolf, Dominik

    2014 - Forschungsinformationssystem des UKE
15. Therapy-related myeloid neoplasms following treatment with radioiodine.

    1. Schroeder, Thomas
    2. Kuendgen, Andrea
    3. Kayser, Sabine
    4. Kröger, Nicolaus
    5. Braulke, Friederike
    6. Platzbecker, Uwe
    7. Klärner, Viola

    2012 - Forschungsinformationssystem des UKE - frei zugänglich